The WFH Humanitarian Aid Program team worked diligently to get the factor to Ukraine as fast as possible. Within days, the donated factor was transported to a warehouse in Europe. From there, it was moved to a storage site on the Polish border, then to Lviv where it was received at Caritas Internationalis, an international charity. Finally, it was relayed to the Lviv Institute of Blood Pathology.
Part of the donations will be kept at the Lviv Institute of Blood Pathology, as many displaced Ukrainians are currently passing through this hub city in the western part of the country. The rest of the donations will be redistributed to other hemophilia treatment centres in the country to ensure patients have access to treatment product despite the dire circumstances caused by the ongoing armed conflict. The WFH has been closely collaborating with the Lviv Institute of Blood Pathology and healthcare professionals to assess the community’s needs. We have also been working with our national member organization (NMO), the Ukrainian Hemophilia Association (UHA), and other patient organizations, to prepare the arrangements for the distribution of donations. The Ukrainian Alliance for Haemophilia & Related Disorders (UAHARD) has provided support by receiving the donated WFH Humanitarian Aid Program treatment products and delivering them to the Lviv Institute of Blood Pathology. The UHA will continue to support the institute and healthcare practitioners (HCPs) with the distribution of products throughout Ukraine.
The WFH would like to thank Sobi, the Lviv Institute of Blood Pathology, Caritas Internationalis, the Ukrainian Hemophilia Association (UHA), and the Ukrainian Alliance for Haemophilia & Related Disorders (UAHARD) for their contributions to make this donation distribution successful. Their passion and support is inspiring. We will continue to monitor the situation, and support and work with our NMOs, partners on the ground and extended networks to ensure we are doing what we can to offer relief and support to all those in need during this crisis. Check in to the WFH News page to keep abreast of breaking news.
If you want to contribute to WFH efforts to support patient organizations and HTCs in Ukraine and in neighbouring countries that are offering aid to refugees displaced by the armed conflict, please visit the WFH “Give” page and enter “Ukraine” in the “Comment” field, or contact Jennifer Laliberté, Director of Strategic and Community Partnerships, at [email protected].
About the WFH Humanitarian Aid Program
The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Founding Visionary Contributors; Bayer and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and our Contributors, CSL Behring and Takeda. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.